Fangying Song

Title: Innovations of Fangying Song in Ophthalmology

Introduction

Fangying Song is a notable inventor based in Qingdao, China. He has made significant contributions to the field of ophthalmology through his innovative research and development of medical solutions. His work focuses on creating effective treatments for eye-related conditions, particularly through the use of advanced materials.

Latest Patents

Fangying Song holds a patent for the "Preparation method of nanozyme composite-based hybrid hydrogel eye drop." This innovative preparation method involves synthesizing a tannin-coordinated silver/cobalt composite nanoparticle through a coordination reaction of cobalt chloride hexahydrate with ammonia water, along with an oxidation-reduction reaction of silver nitrate with tannin. The process includes mixing the silver/cobalt composite nanoparticle with an acrylate-modified gelatin, conducting ultrasonic treatment for complete dissolution, and irradiating the resulting mixture under ultraviolet (UV) light to obtain the hybrid hydrogel eye drop. This method is characterized by its simple operations and short preparation time. The eye drop produced demonstrates a broad-spectrum bactericidal effect against various bacteria and fungi, showcasing significant preventive and therapeutic effects for bacterial and drug-resistant bacterial corneal infections. Fangying Song has 1 patent to his name.

Career Highlights

Fangying Song is affiliated with the Institute of Ophthalmology at Shandong First Medical University, also known as the Shandong Institute of Ophthalmology and Qingdao Eye Hospital. His role at this prestigious institution allows him to engage in cutting-edge research and collaborate with other experts in the field.

Collaborations

Fangying Song has worked alongside notable colleagues such as Weiyun Shi and Hongwei Wang. Their collaborative efforts contribute to the advancement of ophthalmic research and the development of innovative treatments.

Conclusion

Fangying Song's contributions to ophthalmology through his innovative patent and collaborative work highlight his commitment to improving eye care. His research continues to pave the way for new treatments that can significantly impact patient outcomes.